Related Experiment Video

Updated: Jul 3, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients

Jose Eduardo Trevizoli1, Raissa de Paula Menezes, Lara Franciele Ribeiro Velasco

  • 1Hospital de Base do Distrito Federal, Secretaria de Estado de Saúde (SES), Brasília, DF, Brazil. jetrevizoli@terra.com.br

Clinical Journal of the American Society of Nephrology : CJASN
|July 25, 2008
PubMed

Insights

Hepatitis C virus (HCV) patients on hemodialysis show less severe liver disease progression. Uremia may offer a protective effect against liver damage in these patients.

Area of Science:

  • Hepatology
  • Nephrology
  • Virology

Background:

  • The clinical impact of hepatitis C virus (HCV) in patients undergoing hemodialysis remains debated.
  • Understanding liver disease severity in this population is crucial for patient management.

Purpose of the Study:

  • To compare clinical, biochemical, and histological features of HCV in hemodialysis patients versus those with normal renal function.
  • To investigate potential differences in liver disease progression between these two groups.

Main Methods:

  • A case-control study involving 36 HCV patients on hemodialysis and 37 age-, sex-, and infection-time-matched HCV patients with normal renal function.
  • Assessment included biochemical markers, viral load, and liver biopsy analysis for fibrosis and inflammation.

Main Results:

  • Hemodialysis patients exhibited lower alanine aminotransferase levels and reduced HCV viral load.
  • Hepatic fibrosis and inflammatory activity were significantly less prevalent and severe in hemodialysis patients compared to the control group.
  • Tissue inflammation was four times less likely in hemodialysis patients, with severe inflammation being a key predictor of fibrosis.

Conclusions:

  • Hemodialysis and uremia appear to exert a protective role against the progression of liver disease in patients with hepatitis C virus infection.
  • Lower biochemical and inflammatory markers in hemodialysis patients support this protective effect.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...